Nnew drug to treat type 2 diabetes and lose weight
A team of researchers has recently created a new pill
that can significantly improve the health of people with diabetes and
help to shed those extra kilos from their waistlines. The findings
indicated that among patients with type 2 diabetes,
the drug semaglutide taken by pill resulted in better glycemic control
than placebo over 26 weeks. The results from 632 patients indicated that
semaglutide allowed 71 percent of them to shed pounds. It is believed
this is the first type 2 diabetes pill to instigate weight loss.
Although several type 2 diabetes treatments are available, therapy selection involves consideration of the risks of adverse effects such as hypoglycemia (low blood sugar) or weight gain and complexity of treatment. The oral formulation of semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonists (a class of drugs used for the treatment of type 2 diabetes), may improve acceptance and adherence for some patients compared with the injectable formulation of GLP-1 receptor agonists. Researchers randomly assigned 632 patients with Type-2 diabetes and insufficient glycemic control to different doses and dose escalation of once-daily oral semaglutide; oral placebo; or once-weekly semaglutide by injection (subcutaneous) for 26 weeks.
They found that average change in haemoglobin Alc (HbA1c) level, from baseline to week 26, decreased with oral semaglutide and subcutaneous semaglutide and placebo; oral semaglutide reductions were significant vs placebo. From an average baseline HbA1c level of 7.9 percent, between 44 percent and 90 percent of patients receiving oral semaglutide achieved the target HbA1c level of less than seven percent. Clinically relevant (five percent or more) weight loss was achieved in up to 71 percent of patients receiving oral semaglutide.
THIS IS ONLY FOR INFORMATION, ALWAYS CONSULT YOU PHYSICIAN BEFORE HAVING ANY PARTICULAR FOOD/ MEDICATION/EXERCISE/OTHER REMEDIES. PS- THOSE INTERESTED IN RECIPES ARE FREE TO VIEW MY BLOG-
Although several type 2 diabetes treatments are available, therapy selection involves consideration of the risks of adverse effects such as hypoglycemia (low blood sugar) or weight gain and complexity of treatment. The oral formulation of semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonists (a class of drugs used for the treatment of type 2 diabetes), may improve acceptance and adherence for some patients compared with the injectable formulation of GLP-1 receptor agonists. Researchers randomly assigned 632 patients with Type-2 diabetes and insufficient glycemic control to different doses and dose escalation of once-daily oral semaglutide; oral placebo; or once-weekly semaglutide by injection (subcutaneous) for 26 weeks.
They found that average change in haemoglobin Alc (HbA1c) level, from baseline to week 26, decreased with oral semaglutide and subcutaneous semaglutide and placebo; oral semaglutide reductions were significant vs placebo. From an average baseline HbA1c level of 7.9 percent, between 44 percent and 90 percent of patients receiving oral semaglutide achieved the target HbA1c level of less than seven percent. Clinically relevant (five percent or more) weight loss was achieved in up to 71 percent of patients receiving oral semaglutide.
THIS IS ONLY FOR INFORMATION, ALWAYS CONSULT YOU PHYSICIAN BEFORE HAVING ANY PARTICULAR FOOD/ MEDICATION/EXERCISE/OTHER REMEDIES. PS- THOSE INTERESTED IN RECIPES ARE FREE TO VIEW MY BLOG-
HTTP:GSEASYRECIPES.BLOGSPOT.COM/
FOR INFO ABOUT KNEE REPLACEMENT, YOU CAN VIEW MY BLOG-
FOR INFO ABOUT KNEE REPLACEMENT, YOU CAN VIEW MY BLOG-
HTTP://KNEE REPLACEMENT-STICK CLUB.BLOGSPOT.COM/
FOR CROCHET DESIGNS
HTTP://MY CROCHET CREATIONS.BLOGSPOT.COM
FOR CROCHET DESIGNS
HTTP://MY CROCHET CREATIONS.BLOGSPOT.COM
Labels: controls glycemic index, HbA1C, lose weight, new drug, semaglutide, type 2 diabetes
posted by G S Iyer at 4:33 AM
0 Comments:
Post a Comment
<< Home